Incyte Company is an efficient one

Incyte Corporation: “It doesn’t make sense that it’s down here. I think you have a really good one. I think maybe you should buy more than you have. I do not get it. This company actually makes money. It’s really good. I think the big boys will get to that. Nice call. ”

Nautilus biotechnology: “This is an Andreessen Horowitz-[backed] Accompaniment. Look, this is too small to be straightforward to say, ‘You are absolutely right. We have to love it. ‘ I have to work harder on it. It looks very strange because [Amazon founder Jeff] Bezos, it looks like you’re very involved. It’s a strange one. Let me do some work. ”

Corning: “They’re invulnerable for making them, but there are so many other better companies out there for making money. I can’t recommend their stock.”

Icahn company: “No. I think it’s variable [which] is the problem. I don’t know what’s in Icahn Enterprises. He doesn’t tell us. I wish I knew, so it’s too much of a black box to recommend. ”

Join Now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.